These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 13974584
1. Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa). ROCK RL. Arch Ophthalmol; 1963 Mar; 69():330-4. PubMed ID: 13974584 [No Abstract] [Full Text] [Related]
4. Cellular pharmacology of N,N',N''-triethylene thiophosphoramide. Miller B, Tenenholz T, Egorin MJ, Sosnovsky G, Rao NU, Gutierrez PL. Cancer Lett; 1988 Aug 15; 41(2):157-68. PubMed ID: 3135933 [Abstract] [Full Text] [Related]
5. ADJUVANT CHEMOTHERAPY (TRIETHYLENE THIOPHOSPHORAMIDE) WITH RADICAL MASTECTOMY AND RADIOTHERAPY IN BREAST CANCER. HANKINS GW, MCCARTEN AB. Can Med Assoc J; 1963 Dec 28; 89(26):1305-9. PubMed ID: 14101448 [Abstract] [Full Text] [Related]
6. [Study on the use of triethylene thiophosphoramide (THIO-TEPA) in anticancer chemotherapy]. BRULE G, BOIRON M, TRUHAUT R. Pathol Biol; 1963 Dec 28; 11():742-54. PubMed ID: 14016230 [No Abstract] [Full Text] [Related]
7. The effect of triethylene thiophosphoramide (thio-TEPA) in the treatment of incurable neoplastic disease. LEVINE B. J Chronic Dis; 1960 Aug 28; 12():258-64. PubMed ID: 14416250 [No Abstract] [Full Text] [Related]
11. Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia. SHAY H, ZARAFONETIS C, SMITH N, WOLDOW I, SUN DC. AMA Arch Intern Med; 1953 Nov 28; 92(5):628-45. PubMed ID: 13091480 [No Abstract] [Full Text] [Related]
13. RECURRENT PTERYGIUM: USE OF TOPICAL TRIETHYLENE THIOPHOSPHORAMIDE. WESSON TW, PETTIS JL. J Miss State Med Assoc; 1965 Feb 28; 6(2):46-9. PubMed ID: 14256280 [No Abstract] [Full Text] [Related]